financetom
Business
financetom
/
Business
/
Apparel maker HanesBrands' Q2 sales beat estimates, raises full-year outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apparel maker HanesBrands' Q2 sales beat estimates, raises full-year outlook
Aug 7, 2025 4:10 AM

Overview

* HanesBrands ( HBI ) Q2 net sales rise 1.8%, beating analyst expectations, per LSEG data

* Adjusted EPS for Q2 increases 60%, surpassing analyst estimates, per LSEG data

* Co raises full-year 2025 outlook for net sales, operating profit, and EPS

Outlook

* HanesBrands ( HBI ) expects full-year 2025 net sales of $3.53 bln

* Company projects full-year adjusted EPS of $0.66

* HanesBrands ( HBI ) sees third-quarter net sales at $900 mln

* Company anticipates $35 mln tax expense for full-year 2025

Result Drivers

* COST SAVINGS - Gross margin improvement driven by cost savings and productivity initiatives, per CEO Steve Bratspies

* LOWER INPUT COSTS - Gross profit and margin benefited from lower input costs

* SG&A REDUCTION - Operating profit increase attributed to lower SG&A expenses and disciplined expense management

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Beat $991.32 $970 mln

mln (6

Analysts

)

Q2 Beat $0.24 $0.18 (5

Adjusted Analysts

EPS )

Q2 Gross 41.6%

Margin

Q2 Beat $153 mln $136 mln

Adjusted (5

operatin Analysts

g profit )

Q2 41.2%

Adjusted

Gross

Margin

Q2 15.5%

Adjusted

operatin

g Margin

Q2 15.6%

Operatin

g Margin

Q2 $154.66

Operatin mln

g profit

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 4 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the apparel & accessories peer group is "buy."

* Wall Street's median 12-month price target for HanesBrands Inc ( HBI ) is $5.50, about 24.2% above its August 6 closing price of $4.17

* The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 9 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
GlobalFoundries Signs MOU With Singapore Agency to Expand Advanced Packaging Capability
GlobalFoundries Signs MOU With Singapore Agency to Expand Advanced Packaging Capability
May 26, 2025
06:02 AM EDT, 05/20/2025 (MT Newswires) -- GlobalFoundries ( GFS ) said late Monday it signed a memorandum of understanding with Singapore's Agency for Science, Technology and Research, or A*STAR, in a bid to expand its advanced packaging capabilities. GlobalFoundries ( GFS ) will gain access to A*STAR's research and development facilities while providing the latter with critical equipment for...
Weight-loss company Noom pivots to smaller doses of compounded Wegovy
Weight-loss company Noom pivots to smaller doses of compounded Wegovy
May 26, 2025
NEW YORK (Reuters) -Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S. drugs regulator clamps down on mass production of copies of the in-demand medicine. Noom will offer its version of compounded semaglutide - the active ingredient in Wegovy and diabetes drug Ozempic - as part of a program personalized...
Home Depot beats quarterly sales estimates
Home Depot beats quarterly sales estimates
May 26, 2025
May 20 (Reuters) - Home Depot ( HD ) beat Wall Street estimates for first-quarter sales on Tuesday as the world's largest home improvement retailer enjoyed steady demand from professional contractors and small-scale repair works by existing homeowners. The company posted net sales of $39.86 billion for the quarter ended May 4, a 9% jump from last year. Analysts on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved